Zynex Inc.  

(Public, OTCMKTS:ZYXI)   Watch this stock  
Find more results for OTC:ZYXI
0.000 (0.00%)
Delayed:   1:24PM EST
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.16 - 0.20
52 week 0.10 - 0.35
Open 0.16
Vol / Avg. 2,480.00/16,798.00
Mkt cap 6.25M
P/E     -
Div/yield     -
EPS -0.04
Shares 31.27M
Beta -8.96
Inst. own 0%
Nov 6, 2015
Q3 2015 Zynex Inc Earnings Release (Estimated)

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -12.15% -56.05%
Operating margin -8.47% -51.25%
EBITD margin - -65.05%
Return on average assets -25.00% -51.21%
Return on average equity - -336.81%
Employees 92 -
CDP Score - -


9990 Park Meadows Dr
LONE TREE, CO 80124-6739
United States - Map
+1-303-7034906 (Phone)
+1-800-4956695 (Fax)

Website links


Zynex, Inc. operates business through its subsidiaries. The Company has five subsidiaries: Zynex Medical, Inc. (ZMI), Zynex Neurodiagnostics, Inc. (ZND), Zynex Monitoring Solutions, Inc. (ZMS), Zynex Billing and Consulting, LLC (ZBC) and Zynex Europe (Zynex Europe ApS) (ZEU). ZMI designs, manufactures and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. ZND markets electromyography (EMG), electroencephalography (EEG), sleep pattern, auditory and nerve conductivity neurological diagnosis devices to hospitals and clinics. ZMS develops and markets medical devices for non-invasive cardiac monitoring. ZEU is focused on sales and marketing the Company's products within the international marketplace. ZBC provides outsourced billing services for private medical practices, which include collection services, medical coding and general billing consulting.

Officers and directors

Thomas Sandgaard Chairman of the Board, President, Chief Executive Officer, Principal Financial Officer & Accounting Officer
Age: 56